US 9814789
Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma
granted A61KA61K49/0052A61K51/0453
Quick answer
US patent 9814789 (Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma) held by Julius-Maximilians-Universitat Wurzburg expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K49/0052, A61K51/0453, A61P, A61P35/00